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1. INTRODUCTION 
The activity of enzymes can be controlled on the level of individual proteins 
through non-covalent binding of effector molecules or cooperatively by 
substrate binding, and also through covalent protein modification, most often by 
regulatory phosphorylation at serine, threonine or tyrosine residues. In many 
cases these different regulation mechanisms may function together, especially in 
the case of enzymes that play key functions in the crossing points of metabolic 
pathways and therefore need more sophisticated control mechanisms. 
A typical example of the complexity of enzyme regulation can be found in 
the case of pyruvate kinase from liver tissue, which participates in the last step 
of glycolysis, and like other pyruvate kinase isozymes, synthesises ATP from 
ADP and phosphoenolpyruvate (PEP). However, differently from other tissues, 
liver tissue is responsible not only for glycolysis, but also for gluconeogenesis, 
and this fact calls for coordination and even reciprocal regulation of these two 
metabolic pathways, making one inactive while the other is active. One of the 
checkpoints of this regulatory mechanism lies at the crossover of the 
phosphoenolpyruvate/pyruvate transformation catalysed by the liver-type 
pyruvate kinase. Thus the tissue-specific regulatory properties of this enzyme 
play an important role in glucose metabolism. 
Like most known pyruvate kinase isozymes, the enzyme extracted from liver 
tissue also reveals cooperativity towards phosphoenolpyruvate binding, is 
activated by fructose 1,6-bisphosphate, and is inhibited by ATP and alanine 
(Munoz & Ponce, 2003; Flory et al., 1974). However, differently from all other 
pyruvate kinases the liver enzyme is also regulated by phosphorylation of its N-
terminal domain (Munoz & Ponce, 2003; Tanaka et al., 1967). This modi-
fication decreases the activity of the enzyme by increasing the KPEP value and 
the Hill coefficient n for phosphoenolpyruvate. Although on the pheno-
menological level this regulatory effect has been known since the 1970s 
(Ekman et al., 1976), its mechanism and structural background as well as the 
role of the phosphorylatable N-terminal regulatory peptide of the protein in 
general have not been established. 
One reason for this uncertainty is the absence of the crystallographic 
structural data of the N-terminal end of the protein, as due to significant 
flexibility, the positioning of the amino acids of this peptide chain has not been 
determined. Therefore, it was challenging to investigate the regulatory 
mechanism by using the kinetic approach in combination with computer 
modelling of protein structure and docking sites. This analysis has provided 
unique information about the regulation of the enzyme activity and might have 
implications for deeper understanding of the regulatory phosphorylation 
phenomena in general. 
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2. PYRUVATE KINASES 
2.1. Occurrence and functions 
Pyruvate kinases (ATP-pyruvate-O-phosphotransferase, EC 2.7.1.40, PK) are 
enzymes involved in the glycolytic metabolic pathway, which is the crucial 
component of energy metabolism in cells and carbon metabolism in general. 
These enzymes catalyse the final step of glycolysis, transferring the phosphoryl 
group of phosphoenolpyruvate (PEP) to ADP, producing pyruvate and ATP 
(Bugg, 2001; Mesecar & Nowak, 1997ab; Sowadski & Epstein, 2001):  
 
 
 PEP  +  ADP                       pyruvate  +  ATP          (1) 
 
 
The actual role of pyruvate kinases depends on the needs of the tissue, and these 
enzymes may control consumption of metabolic carbon for biosynthesis and 
also utilisation of pyruvate for energy production. In muscle and brain tissues 
glucose is metabolised for energy production to CO2 and water, or to lactate 
under anaerobic conditions. However, in liver tissue both glycolysis and 
gluconeogenesis may occur simultaneously, although the main function of the 
liver is gluconeogenesis, conversion of pyruvate into glucose or into fatty acids 
via acetyl-CoA may occur. In mammals about 90% of blood glucose is 
produced by gluconeogenesis in the liver. Therefore, it is important to regulate 
pyruvate kinase activity, to prevent substrate cycling between phospho-
enolpyruvate and pyruvate. Subsequently PK can be considered as a switch 
between glycolysis and gluconeogenesis. And moreover, the level of ATP in the 
cell can be controlled through regulation of pyruvate kinase activity (Fenton & 
Hutchinson, 2009; James & Blair, 1982; Mesecar & Nowak, 1997ab; Jurica et 
al., 1998; Valentini et al., 2000, 2002). This option is illustrated in Figure 1.  
Due to multiple functional requirements different isozymes of PK can be 
found in higher organisms, while bacteria and lower eukaryotes have only one 
form of PK. However, there are some bacteria that have two isoforms of this 
enzyme. Plants have 2 isoforms of PK, located in cytoplasm and plastids, 
respectively.  
In mammalian tissues 4 PK isozymes are known, and these proteins are 
encoded by 2 genes (M and L loci) (Munoz & Ponze, 2003). These isozymes 
have been denoted by the following abbreviations:  
 
M1 – found in skeletal muscle, heart and brain,  
M2 – found in kidney, adipose tissue and lungs,  
L  – extracted from liver  
R – found in erythrocytes 
 
Mg2+, K+ 
PK 
3
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Figure 1. Reciprocal Regulation of Glycolysis and Gluconeogenesis (Biochemistry 
2012, seventh edition, Freeman and Company, reproduced by permission) 
 
The isozymes M1 and M2 are encoded by one gene with transcription by two 
different mRNAs. Similarly L and R isoenzymes are produced from the same 
gene by using different promoters (Noguchi et al., 1987). All these isozymes 
have similar structure and comparable functions, but their kinetic and regulatory 
properties may still be different, and these differences are governed by the 
specific metabolic requirements of the expressing tissue, as was stressed above.  
It is generally accepted that only the M1 isozyme follows hyperbolic 
Michaelis-Menten kinetics, while the activity of the M2, R and L subtypes 
reveals more complex regulatory patterns. This pattern includes homotropic 
regulation by one of the substrates of this reaction, PEP, and heterotrophic 
regulation by different signal molecules, among which FBP has central impor-
11 
tance (Munoz & Ponze, 2003; Mattevi et al., 1996; Valentini et al., 2000; Jurica 
et al., 1998). In the case of homotropic regulation, substrate is at the same time 
an effector of the multimeric enzyme. In other words, the binding of the 
substrate molecule to the multimeric enzyme influences binding of the next 
molecule of the same substrate. Heterotrophic regulation means that binding 
effectiveness of a substrate molecule is changed in the presence of an effectors 
molecule, which binds to a distinct effector binding site (Berg, 2012; Bindslev, 
2008; Monod et al., 1965) So, in the presence of the allosteric regulator FBP, 
pyruvate kinases exhibit hyperbolic dependence of reaction velocity on PEP 
concentration (Ekman et al., 1976). 
The activity of L-type PK can be additionally regulated through 
phosphorylation of the serine 12 residue of its N-terminal domain. As a result of 
phosphorylation the affinity of PEP to L-PK decreases and cooperativity 
coefficient n increases. All other types of pyruvate kinases lack this regulatory 
mechanism (El-Maghrabi et al., 1980, 1982; Pilkis et al., 1980, Muirhead et al., 
1986). Historically, discovery of phosphorylation of L-PK has made a 
significant contribution to development of the concept of regulatory 
phosphorylation in general (Hers & Van Schaftingen, 1984). However, the 
molecular mechanism of L-PK activity regulation is still not well understood, 
and several aspects of this phenomenon will be discussed later in this 
dissertation.  
Taken together, the diversity of regulation mechanisms of pyruvate kinase 
activity seem to be important for their functioning as the key enzymes 
regulating the glycolytic pathway and thus controlling both the energetic and 
metabolic statuses of living cells. 
 
 
2.2. Structure of pyruvate kinases 
The primary structure of pyruvate kinases is highly conserved among different 
organisms, and a significant similarity can also be observed in the spatial 
structure of these enzymes. The predominant and functionally active form of 
these enzymes is tetrameric (Figure 2), but they can also exist in monomeric up 
to decameric form (Munoz & Ponze, 2003). In mammalian tissues all 
functionally active isozymes are tetrameric and they consist of four similar 
subunits. 
The molecular mass of the tetrameric PKs is around 220-250 kDa (Valentini 
et al., 2002), and each subunit consists of about 500 amino acid residues and 
has a molecular mass of 55–60 kDa (Knowless et al., 2001).  
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Figure 2. The PK tetramer shown here has subunit 1 in blue, subunit 2 in yellow, 
subunit 3 in green, and subunit 4 in red (Protein Data Bank, PDB ID 1liu). 
 
Each subunit of PK can be divided into 3 domains – A, B and C (Figure 3). In 
addition, some types of PK have a relatively small N-terminal domain. In the 
tetrameric enzyme structure these domains are located in such a way that the  
N-terminal domain and the sequence that links domains A and C are at the 
centre of the molecule (Pendergrass et al., 2006). All domains are connected to 
each other through covalent bonds: there is one covalent bond between the  
N-terminal domain and domain A, two covalent bonds between domains A and 
B, and one covalent bond between domains A and C (Munoz & Ponce, 2003; 
Muirhead et al., 1986).  
The tetrameric structure of these enzymes can be divided into four parts, 
separated by inter-subunit planes, which mark the contacting surfaces of the 
interacting subunits (Munoz & Ponze, 2003, Jurica et al., 1998, Muirhead et al., 
1986). 
Domain A is characterised by (α/β)8 topology, domain B by an irregular β 
barrel and domain C can be characterised with α/β organisation. An additional 
the N-terminal domain is usually formed by a helix-turn-helix motif (Mattevi et 
al., 1996; Valentini et al., 2000), in some cases its structure has not been 
determined by X-ray analysis due to the high flexibility of this peptide. This is 
the case for the liver-type isozyme studied in this work.  
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Figure 3. The PK subunit structure, calculated proceeding from data in the Protein Data 
Bank (PDB ID 2VGB). The K+ and Mn2+ ions are denoted by violet and yellow spheres, 
respectively, and the position of amino acid 26, which is linked to the N-terminal 
domain, is denoted by the arrow, while amino acids 1–25 of this regulatory domain are 
not shown.  
 
The active site of the pyruvate kinase subunit is located in a pocket between A 
and B domains. The PEP binding site is located in domain A, along with the 
binding sites for monovalent and bivalent cations (usually Mg2+ and K+), which 
are required for the PK catalysed reaction (Muirhead et al., 1986). This site 
contains three positively charged residues: lysine and two arginine residues, as 
well as four negatively charged side chains: two glutamic acids (E) and two 
aspartic acids (D). In some species one E-residue can be absent. The second 
pyruvate kinase substrate ADP binds closer to the centre of domain A. The 
same location is used for binding of ATP, which is the product of the reaction 
and also acts as an inhibitor in some types of PK (Munoz & Ponce, 2003). 
Domains C and N are situated in sites of inter-subunit contact, so they can 
play essential role in assembly and intermolecular communication (Wooll et al., 
2001). The allosteric effector FBP binds to the pocket located between the A 
and C domains, closer to the C domain. This site is characterised by a cluster of 
positively charged residues (Mattevi et al., 1996; Munoz & Ponce, 2003). Thus 
domain C is responsible for regulation of PK activity by this allosteric modulator.  
Another structural element participating in allosteric regulation of L-type PK 
is the N-terminal domain, as the activity of this isozyme can be regulated 
through phosphorylation of Ser 12 residue located in the following peptide 
sequence of this domain (Mattevi et al., 1996; Munoz & Ponce, 2003): 
 
4
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 MEGPAGYLRR10ASVAQLTQEL20GTAFF … (2) 
 
There are some differences in the amino acid sequence between the M1 and M2 
types, mostly located in the C domain of the pyruvate kinase subunit. This 
domain is probably responsible for the allosteric behaviour of the enzyme 
induced by the allosteric activator FBP, as the binding site of this activator lies 
in the same domain. These structural differences also manifest in the kinetic 
properties of these enzymes, as M1 is not allosterically regulated via binding of 
the allosteric modulator to the C domain (Noguchi et al., 1986; Friesen & Ching 
Lee, 1998). 
The primary structure of the R and L isozymes are very highly conserved, 
while the R type pyruvate kinase subunit is about 3500 Da larger. This 
difference is connected with the length of the N-terminal domains, as this 
peptide is 31 amino acid residues longer in the case of the R-type isoenzyme. 
The crystal structure of the R-type enzyme is available, but without revealing 
the positions of 49 amino acids belonging to this highly flexible N-terminus. 
Analogously, in the currently available crystal structure of human L-PK the first 
26 amino acid residues of the N-terminus are not defined. Therefore, it is 
unclear how this peptide is located and how its phosphorylation may affect the 
catalytic properties of L-PK, as suggested in several papers (Noguchi et al., 
1987; Friesen & Ching Lee, 1998, Pendergrass et al., 2006, Fenton & Tang, 
2009; Prasannan et al., 2012). 
Some differences between amino acid compositions can also be seen in the 
binding region of allosteric effectors in the C domain (Jurica et al., 1998). For 
example, differences in amino acid sequence were observed in the allosteric 
rabbit kidney PK and non-allosteric muscle PK and these differences were 
mostly located in the C domain and probably participate in inter subunit 
interactions (Lee, 2008). Comparing the structures of the M1 and M2 enzymes, 
encoded by M gene with alternative splicing, it was also found that the non-
allosteric M1 isozyme and the allosterically regulated M2 isoenzyme differ by 
the presence of a glutamic acid residue in the region of the FBP binding site, 
and it was supposed that this negatively charged amino acid either prevents 
negatively charged FBP binding or mimics it (Jurica et al., 1998). 
 
 
2.3. Catalysis and binding steps 
As was mentioned above, pyruvate kinases catalyse the formation of ATP and 
pyruvate in the last step of glycolysis. This catalytic reaction can be presented 
by two steps. The first step is the transfer of phosphoenolpyruvate phospho-
group to MgADP, and the second step is a rapid conversion of enolpyruvate 
into its keto form (Muirhead et al., 1986; Metzler, 2001). Schematically these 
steps are shown in Figure 4. 
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Figure 4. Two steps of pyruvate kinase catalysed reaction  
 
However, the rate of these catalytic steps, quantified by kcat (or Vmax) value, 
seems not to be controlled by factors, which regulate the observed activity of 
pyruvate kinases (Munoz & Ponze, 2003). Therefore, in most cases this activity 
regulation should occur via control of the binding steps of substrates. This 
conclusion is valid for the influence of the allosteric effector FBP, which 
regulates the activity of mammalian M2, R and L type pyruvate kinases, and 
also the activity of some prokaryotic and eukaryotic PKs (Mesecar & Nowak, 
1997b; Munoz & Ponze, 2003; Dombrauckas et al., 2005).  
However, most interestingly, the survey of the existing data demonstrates 
that even this regulation is asymmetric, as only the binding effectiveness of PEP 
is subjected to alterations, while the binding effectiveness of ADP is in most 
cases practically not affected. This fact may have importance from the point of 
metabolic turnover and can be used by a cell for more sensitive control over the 
glucose level.  
 
 
2.4. Transitions between T-state and R-state 
Two states of PK are distinguished: the less active T-state and the more active 
R-state. The M1 isozyme is mostly in active R state and therefore its activity is 
not controllable by allosteric ligands. Other isozymes obviously undergo 
conversion between the T and R states. These transitions were described in the 
case of Leishmania pyruvate kinase, for which different ligand complexes were 
studied by X-ray analysis and the accompanying structural changes were 
characterised (Morgan et al., 2010). However, the main structural principles of 
these transitions have already been described in earlier papers.  
16 
For conversion from T to R state two types of rotations are observed. Firstly, 
rotation of domains B and C within every subunit can be detected. Secondly, 
rotation of the whole subunit within the tetramer occurs. During this transition 
domains undergo modification of their relative orientation up to 29o. As a result 
of these changes, the PEP binding site is distorted or vice versa, depending on 
the direction of the transition (Mattevi et al., 1996; Valentini et al., 2000). This 
situation is illustrated in Figure 5.  
 
 
Figure 5. The rotations of domains and subunits of the PK tetramer, occurring on the 
conformational transition of pyruvate kinase inactive form T to the active form R.  
T-state is on the left (Mattevi et al., 1996). 
 
Ching Lee investigated the R and T states of rabbit muscle pyruvate kinase. He 
found that PEP binding is accompanied by rotation of the B domain relatively to 
the A domain. This rotation leads to closure of the cleft between these domains, 
and locks the enzyme in the R-state. A similar effect was also observed in the 
presence of ADP (Lee, 2008). However, binding of phenylalanine causes 
opening of the same cleft. As a result of this, the less active state is stabilised 
and phenylalanine acts as an inhibitor of the M2 isozyme, characterised by the 
IC50 value 0,24 mM (Morgan et al., 2013). On the other hand, the well-known 
allosteric activator FBP shifts this equilibrium toward the active R-state, and 
this effect was described by AC50 = 7μM for the M2 isozyme. Most 
interestingly, the activity of the enzyme activated by FBP is very similar to the 
activity of the M1 isozyme, which is in the fully active form at all times 
(Morgan et al., 2013).  
Transitions between T and R states can also be induced by differences in the 
primary structure of proteins. So, the differences between the primary structures 
of rabbit muscle PK and kidney PK include 22 amino acid residues. All these 
17 
residues are not located in the active site region, but can be found in the  
C-domain region, which participates in inter-subunit contact. This change in a 
relatively small number of amino acid significantly changes the allosteric 
properties and binding constants of ligands: the muscle PK stays preferably in 
the active R-state, while the kidney PK prefers the inactive T state (Lee, 2008).  
Enzyme transition from the more active R state to the less active T state by 
allosteric ligand can be observed as enzyme inhibition. On the other hand, 
however, inhibition may also occur through shifting equilibrium between tetra-
meric and monomeric enzyme forms. The thyroid hormone (triiodo-l-thyronine, 
T3) stabilises the inactive monomeric form of M2-PK, and this inhibition effect 
was characterised by the IC50 value 78nM (Morgan et al., 2013). 
 
 
2.5. Effect of ligands on pyruvate kinase activity 
The inhibitory effect of amino acids is a common phenomenon for all 4 
mammalian isozymes. However, particular inhibitory amino acids may be 
different for different enzyme subtypes. For example, the activity of the M1 
subtype can be inhibited by various hydrophobic amino acids, and 
phenylalanine is clearly an allosteric inhibitor of this enzyme, causing a 
decrease of the enzyme affinity toward PEP. Another amino acid, alanine, 
elicits a negligible allosteric response in the case of the M1 subtype, but 
increasing hydrophobicity of the compound, for example by the addition of 
methyl groups, increased the role of the allosteric inhibition. Differently from 
M1 and M2 isoenzymes R- and L-types of PK can be allosterically inhibited by 
ATP (Feksa et al., 2003; Williams et al., 2006). 
The affinity of PK for allosteric regulators depends on pH. For example, the 
increase of pH from 6.5 to 8.0 caused a lowering of the L-PK affinity towards 
PEP and FBP, but at the same time slightly increased affinity for inhibitors like 
alanine and ATP. The allosteric effect of ATP and FBP increased at higher pH 
values, while the effect of alanine was not affected by pH (Fenton & 
Hutchinson, 2009). 
It is known that the pyruvate kinase catalysed reaction requires the presence 
of both bivalent and monovalent cations, most commonly Mg2+ and K+, which 
are considered as physiological activators. But there are bacterial PKs that don’t 
need the presence of K+ (Munoz & Ponce, 2003).  
It is remarkable that not only Mg2+ and K+, but also other monovalent and 
bivalent cations can be used as activators: for example Mn2+, Co2+, NH4+, and 
also Na+. However, this replacement of cations is possible only in the presence 
of FBP (Hunsley & Suelter, 1969; Mesecar & Nowak, 1997ab; Muirhead et al., 
1986; Munoz & Ponze, 2003).  
Two bivalent cations per subunit are needed in the case of non-allosteric 
muscle pyruvate kinase. One of these ions binds directly to the enzyme, 
interacting with side chains of glutamic acid and aspartic acid (positions 271 
5 
18 
and 295, respectively, rabbit muscle enzyme), which are situated in the  
A-domain, and are completely conserved in PKs from different sources (Munoz 
& Ponze, 2003, Larsen et al., 1994). Another ion doesn’t interact with the 
enzyme and coordinates phosphoryl groups of nucleotides. 
The role of bivalent cations was described in literature as follows: Mg2+ 
reduces the electrostatic repulsion between the phosphodonor (PEP) and the β 
phosphogroup of ADP, acting as a nucleophile. It was suggested that Mg2+ 
coordinates the phosphogroups of phosphoenolpyruvate and ADP in the large 
active site pocket and then the transfer of phosphogroup from PEP to ADP takes 
place (Muirhead et al., 1986; Mesecar & Nowak, 1997ab; Oria-Hernandez et al., 
2005). 
It was suggested that the monovalent cation K+ binds to glutamine and 
glutamic acid residues (positions 328 and 363, respectively, cat muscle PK). 
These residues are conserved in different PKs, but glutamine can be substituted 
by asparagines in some cases (Muirhead et al., 1986; Munoz & Ponze, 2003). 
The spherical electron density of K+ lies in the pocket, formed by the amino 
acids N-74, S-76, D-112 and T-113, rabbit PK. N-74 and D-112, which are 
completely conserved in all PKs (Larsen et al., 1994; Munoz & Ponze, 2003). It 
was also noticed that PKs, where T-113 and E-117 are replaced by L and K, 
don’t need K+ for activity. Therefore, it was suggested that the protonated  
ε-amino group of K can perform the role of an internal monovalent cation 
(Laughlin & Reed, 1997; Munoz & Ponce, 2003). 
In spite of the fact that the role of K+ is not totally understood, it was 
demonstrated that K+ is involved in the formation of the active conformation of 
the enzyme (Oria-Hernandez et al., 2005). It was also proposed that K+ parti-
cipates in the coordination of the PEP carboxyl group and in phosphate group 
transfer (Muirhead et al., 1986). When the monovalent cation is absent, ADP 
cannot bind to an enzyme without primary binding of the second substrate PEP. 
Therefore, it was concluded that in the absence of K+ the binding process 
follows an ordered mechanism with PEP binding as the first substrate. 
Otherwise the reaction follows a random kinetic mechanism (Oria-Hernandez et 
al., 2005; Muirhead et al., 1986; Mesecar & Nowak, 1997ab). 
In summary, it can be concluded that the presence of Mg2+ and K+ is needed 
for the sigmoid shape of the reaction initial rate versus PEP concentration. 
However, in the presence of FBP the Mg2+ activated enzyme follows hyperbolic 
kinetics toward PEP. If Mg2+ ions are substituted by Mn2+ PK shows hyperbolic 
kinetics toward PEP. Therefore, it can be suggested that Mn2+ ions can mimic 
the allosteric effect of the heterotropic activator FBP. Moreover, it was also 
shown that the Mn2+ activated L-PK was not allosterically regulated by FBP, 
and doesn’t require monovalent cations for its activity. If monovalent cations 
Na+ or Li+ are used instead of K+, the allosteric response to FBP binding 
decreases (Mesecar & Nowak, 1997ab; Fenton & Ponce, 2003; Alontaga & 
Fenton, 2009).  
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2.6. Point mutations and  
pyruvate kinase allosteric regulation 
Among the four mammalian isoenzymes only M1 does not reveal cooperativity, 
and its affinity for PEP was characterised by the KPEP value 0.049 mM (Ikeda et 
al., 1997). However, substitution of A-398 by R in domain C generated coope-
rative regulation of the enzyme activity by PEP, characterised by the Hill 
coefficient 2.7 and the KPEP value 0.41 mM for this substrate (Ikeda et al., 1997). 
At the same time the affinity of the mutant enzyme for ADP was the same as in 
the case of the wild type enzyme. More interestingly, the mutant form was 
allosterically regulated by FBP, although this effect was not observed in the 
case of the wild type enzyme. It was concluded that this single point mutation 
shifted the equilibrium between the T and R states towards the T-state, while the 
wild type enzyme with A in position 398 is preferably in the R state (Ikeda et al., 
1997).  
Alternatively, an attempt was made to change the allosterically regulated 
enzyme into a non-allosteric enzyme by introducing point mutations into the 
same region of rat M2 PK, and this experiment was successful. Replacement of 
C 423 residue by L in the allosterically regulated rat M2 isozyme resulted in the 
loss of both homotropic and heterotropic allosteric effects observed in the case 
of PEP: the Hill coefficient decreased from 2.3 to 1.3 and the apparent KPEP 
decreased from 0.18 mM to 0.047 mM. And again, the binding effectiveness of 
the second substrate ADP was not affected by this point mutation (Ikeda & 
Noguchi, 1998). 
For a more systematic analysis of the interrelationship between allosteric 
regulation of PK activity by FBP and point mutations, the full list of mutated 
proteins and their catalytic properties was compiled (Fenton & Blair, 2002). 
This analysis revealed that in the case of yeast PK mutation E392A eliminated 
all effects of cooperativity and allosteric regulation. At the same time mutation 
R369A had only moderate effect on allostery, although both amino acids E392 
and R369 are located in the same C-C interface between two subunits of the 
tetrameric enzyme. The same analysis revealed that seven mutations made at the 
A-C interface within the same subunit had no influence on allostery. Further, 
mutation T311M was done in the interface A-A between two subunits and this 
change decreased the affinity of PK for PEP and FBP. Another mutation in the 
same location, Q299N, made ADP binding controllable by FBP. Finally, point 
mutations T403K, T406R, A458K made in the vicinity of the FBP binding site 
revealed that the introduction of a positive charge into these positions had a 
minor effect on FBP binding, while FBP binding effectiveness was strongly 
reduced in T403E and R459Q mutants (Fenton & Blair, 2002).  
Rabbit muscle PK and rabbit kidney PK have a region that contains 22 
different amino acids, and several point mutations were made in this part of the 
protein molecule (Lee, 2008). In the mutant S402P of rabbit muscle enzyme, 
only partial appearance of enzyme cooperativity was observed (Lee, 2008). 
20 
Further, the T340M mutant that is characteristic of patients with pyruvate kinase 
deficiency was studied. It was found that the activity of mutated PK decreased 
twice, and the mutant became more sensitive to the inhibitory effect of 
phemylalanine, but was not regulated by FBP (Lee, 2008, Cheng et al., 1996). 
Taken together, these results demonstrate that the allosteric regulatory 
effects should embrace different parts of the protein molecule, and single 
modifications may be sufficient for switching on and switching off coope-
rativity and allosteric regulation, especially if the ionic status of the binding site 
is affected. 
 
 
2.7. Regulatory phosphorylation  
of L-type pyruvate kinase 
In the case L-type pyruvate kinase an additional regulatory mechanism exists. 
This regulation is connected with phosphorylation on the N-terminal domain of 
this enzyme. The phosphorylation reaction takes place at the serine residue in 
position 12 of this sequence and down regulates the enzyme activity by 
reducing the binding effectiveness of PEP without significant effect on the Vmax 
value. At the same time no effect was observed in the case of ADP binding. 
Phosphorylation of the regulatory N-terminal also decreases the binding 
effectiveness of the allosteric ligand FBP, while the affinity of the enzyme for 
inhibitors ATP and alanine increases. Therefore, it was concluded that 
phosphorylation shifts equilibrium between the active R state and inactive T 
state of the liver enzyme toward the less active T-state, and enhances 
cooperativity of the catalytic reaction (El-Maghrabi et al., 1980, 1982; Pilkis et 
al., 1980).  
The dependence of L-PK activity upon the degree of phosphorylation of the 
enzyme and lowering of the enzyme affinity for PEP by this regulatory event 
was already described in 1974 (Ljungström et al., 1974). Further studies 
confirmed the interrelationship between the extent of protein phosphorylation 
and its affinity for PEP. So, the enzyme purified from rat liver contained 
3 moles of phosphate per mole of tetrameric enzyme and was characterised by 
the  value 1.2 mM. Further, in the presence of 1 mole of phosphate per 
mole of tetrameric enzyme the KPEP value was 0.7 mM, and in the case of the 
fully phosphorylated enzyme (4 mole of phosphate per mole of tetramecic 
enzyme) the KPEP value 1.4 mM was obtained (El-Maghrabi et al., 1980). The 
increase in the KPEP values was accompanied by an increase in the Hill coeffi-
cient, characterising the cooperativity of the system. Moreover, phosphorylation 
also decreased the binding effectiveness of the allosteric regulator FBP  
(El-Maghrabi et al., 1982).  
 
 
KPEP
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2.8. Role of N-terminal domain in L-PK activity 
The activity of L-PK can also be reduced by limited proteolysis of the  
N-terminal domain, and this effect was first described in 1978 (Bergström et al., 
1978), and a more detailed study of proteolytic truncation of the N-terminal part 
of L-PK confirmed these results (Fenton & Tang, 2009). It was found that 
shortening of the N-terminal end (see Eq. 2) by 6 amino acids had practically no 
effect on PEP binding, while removal of the following 7 to 12 amino acids 
reduced PEP binding effectiveness. Further truncation had again no additional 
effect on PEP binding effectiveness (Fenton & Tang, 2009). Thus truncation 
and phosphorylation seem to have a rather similar influence on the catalytic 
properties of L-PK, and it was even claimed that truncation of the N-terminus 
peptide mimics the effect of phosphorylation, decreasing the similarly affinity 
of the enzyme toward PEP (Fenton & Tang, 2009). 
Further, the phosphorylatable S12 residue was substituted by aspartic acid 
residue, and the kinetic properties of the S12D mutant were studied. It was 
found that this mutant indeed mimicked the kinetic properties of phosphorylated 
L-PK by decreasing PEP binding effectiveness, which became comparable to 
that of the phosphorylated enzyme. Moreover, the removal of the initial 10 
residues of S12D had no effect on the apparent KPEP value (Fenton & Tang, 
2009). 
On the basis of these results a hypothesis was proposed that the N-terminus 
of non-phosphorylated enzyme interacts with the main body of L-PK and 
activates the enzyme by increasing its affinity for PEP (Fenton & Tang, 2009). 
Phosphorylation, proteolytic truncation and S12D mutation obviously hampered 
this interaction and reduced PEP binding effectiveness. Most significantly, in 
the presence of peptides that were derived from the protein N-terminus, the 
activity of the S12D mutant enzyme was increased, pointing to the possibility 
that these peptides mimic interaction of the N-terminal domain with the protein 
main body, and increase its affinity for PEP (Prasanan et al., 2012). The 
oxidation of Cys 436 residue of the main body of PK also resulted in a decrease 
of the enzyme affinity for PEP, pointing to the fact that this oxidation may 
prevent the interaction of N-terminus with the protein main body (Holyoak et 
al., 2013). 
 
6
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3. OBJECTIVES OF DISSERTATION 
The main objectives of this work were: 
 
1. Investigation of the kinetic properties of non-phosphorylated L-type pyru-
vate kinase. 
 
2. Investigation of the role of the N-terminal regulatory domain in activity of 
L-type pyruvate kinase by using point mutations around phosphorylatable 
serine residue. 
 
3. Investigation of the interaction of non-phosphorylated pyruvate kinase with 
ligands that evoke allosteric effects in the case of the phosphorylated enzyme. 
 
4. Kinetic study of the catalytic properties of the phosphorylated L-type 
pyruvate kinase. 
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4. MATERIALS AND METHODS 
4.1. Chemicals 
Adenosin-5’-diphosphate disodium salt (ADP), phosphoenolpyruvate (PEP) 
tricyclohexylammonium salt and bovine serum albumin (BSA) fraction V, were 
purchased from Boehringer Mannheim GmbH, Germany. Nicotinamide adenine 
dinucleotide reduced form disodium salt (NADH) and fructose-1,6-biphosphate 
trisodium salt (FBP) was from Sigma Chemical Co. Tris(hydroxymethyl)-
aminomethane (TRIS), dithiothreitol (DTT) and protein molecular mass 
markers (bovine serum albumin, bovine liver catalase, ovalbumin and carbonic 
anhydrase) were obtained from Sigma-Aldrich (USA). MgCl2 and KCl were 
from Acros. [γ-32P]ATP was obtained from Amersham (UK) (110 TBq/mmol). 
The DE-52 ion-exchanger was from Whatman and hydroxyapatite from BioRad. 
Peptides RRASVA, RRAAVA and RRAS(Pi)VA were purchased from GL 
Biochem (Shanghai) Ltd (China), sale confirmation number GLS-P060704. 
These samples were characterised by HPLC and ESI-MS data and had purity 
above 95%. All other chemicals of highest purity grade available were 
purchased from Sigma-Aldrich (USA). The Milli-Q deionized water was used 
in all experiments. 
 
 
4.2. Enzymes 
The recombinant expressed catalytic subunit of mouse cAMP-dependent protein 
kinase (PKA, 0.1 mg/ml, 30 U/mg, Lot 040916) was obtained from Biaffin 
GmbH and Co KG (Germany). Before experiments the protein solution was 
diluted 300 – 1000-fold in 50 mM Tris-HCl buffer (pH 7.5) containing 1 mg/ml 
BSA, and the stock solution was kept in an ice bath until use. 
Lactate dehydrogenase from rabbit muscle (LDH) was purchased from 
Boehringer Mannheim GmbH, Germany. Solution of this enzyme was diluted 
about 400 times to 0.002 mg/ml (1.5 units/ml). 
The wild type and mutant forms of rat liver pyruvate kinase were over-
expressed in E.coli and purified by Mart Loog and Nikita Oskolkov in Uppsala 
University. This procedure and obtained products were described in detail 
before (Loog et al., 2005), and the proteins were kindly provided for this study. 
The point mutations were introduced into the N-terminal domain of L-PK at 
positions 9, 10 and 13 near the phosphorylatable S12 residue:  
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The wild type protein: 
MEGPAGYLRR10AS12VAQLTQEL20GTAFF… 
 
Mutant proteins: 
MEGPAGYLAR10AS12VAQLTQEL20GTAFF… 
MEGPAGYLKR10AS12VAQLTQEL20GTAFF…  
MEGPAGYLER10AS12VAQLTQEL20GTAFF… 
MEGPAGYLQR10AS12VAQLTQEL20GTAFF… 
MEGPAGYLRA10AS12VAQLTQEL20GTAFF… 
MEGPAGYLRK10AS12VAQLTQEL20GTAFF… 
MEGPAGYLRQ10AS12VAQLTQEL20GTAFF… 
MEGPAGYLRL10AS12VAQLTQEL20GTAFF… 
MEGPAGYLRR10AS12AAQLTQEL20GTAFF… 
MEGPAGYLRR10AS12EAQLTQEL20GTAFF… 
 
The structure of proteins was verified by DNA sequencing, all the enzymes 
were purified to homogeneity and this purity was checked by SDS-PAGE 
electrophoresis as was described in (Loog et al., 2005). The enzyme solutions 
were made by dilution of the stock solutions with 50 mM TRIS-buffer (pH 7.4), 
containing 0.1% BSA.  
 
 
4.3. Protein concentration 
The enzyme concentration was measured spectrophotometrically by the 
absorbance of tryptophane (Trp), tyrosine (Tyr) and cysteine (Cys) at 280 nm as 
described by Aitken & Learmonth, 2002. On the basis of the primary structure 
of the protein (Noguchi et al., 1987; Lone et al., 1986) protein the number of 
these amino acid residues was evaluated (Trp – 3, Tyr – 10, Cys – 6) and 
according to this composition the extinction coefficient 30590 M–1sm–1 was 
calculated for the L-PK subunit. 
 
 
4.4. SDS-PAGE electrophoresis 
The analysis was done according to the Laemmli protocol modified by 
O’Farrell in 12% SDS-polyacrylamide gel (O´Farrel, 1975). After electro-
phoresis visualisation of proteins was performed by colloidal staining in 1.6% 
ortho-phosphoric acid, 8% ammonium sulphate, 0.08% of Coomassie brilliant 
blue G-250 and 20% methanol. Destaining was carried out in water. Protein 
molecular mass markers were bovine serum albumin, bovine liver catalase, 
ovalbumin and carbonic anhydrase from Sigma-Aldrich. 
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4.5. L-PK phosphorylation 
The phosphorylation of L-PK was carried out at 30C in a 50 mM TRIS/HCl 
buffer (pH 7.5), containing 100 µM of -[32P]ATP (specific radioactivity 
380 cpm/pmol), 10 mM MgCl2, 0.967 mg/ml of PKA and BSA (1 mg/ml). The 
phosphorylation reaction was started by the addition of PKA to the reaction 
mixture, and L-PK phosphorylation was followed by analysing samples taken 
from this reaction mixture at appropriate time moments. Firstly, 10 μl of these 
aliquots were applied to pieces of phospho-cellulose paper P81 (Whatman, UK) 
and immersed in ice-cold phosphoric acid (75 mM). Then the pieces of paper 
were washed 4 times for 10 minutes with additional amounts of phosphoric acid, 
dried at 120ºC for 25 minutes and counted for bound radioactivity on a scintilla-
tion counter RacBeta 1219 OK (USA). Secondly, at the end of the reaction, the 
last sample was taken into a Sephadex G50 mini-column (bed volume 0.5 ml) and 
the phosphorylated protein was separated from the excess of [-32P]ATP by gel-
filtration. The eluent was collected drop-wise on pieces of Whatman filter paper, 
dried at 120ºC and counted for radioactivity as described above. 
 
 
4.6. FPLC analysis 
Fast protein liquid chromatography (FPLC analysis) was performed to 
determine the molecular weight of the enzymes. The protein sample (100–
200 μl) was applied to a Superdex 200 HR 10/30 column and gel filtration was 
performed in a 50 mM Tris/HCl buffer containing 150 mM NaCl at a flow rate 
0.5 ml/min. at room temperature, using an ÄKTA FPLC system (Amersham 
Biosciences, Sweden). Markers used for molecular weight determination were: 
myoglobulin (MW = 17,000 Da), ovalbumin (MW = 45,000 Da), bovine serum 
albumin (MW = 66,000 Da), immunoglobulin (MW = 140,000 Da), catalase 
(MW = 232,000 Da) and ferritine (MW = 440,000 Da). The calibration curve 
was constructed using the set of standard proteins. It is the relationship between 
Kav for each protein that characterises the elution volumes and the logarithm of 
their respective molecular weights, (Figure 6). Kav was calculated using the 
following equation (Eq. 3): 
 
 
 
 0
0
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VVK
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av 
                                             (3) 
 
where Ve – elution volume for the protein, V0 – column void volume (elution 
volume for Blue Dextran), Vt – total bed volume. The molecular weights for all 
enzymes were calculated from the obtained calibration curve. Comparison of 
molecular masses of the phosphorylated and non-phosphorylated L-PK was 
shown in Figure 6. It can be seen that both these proteins were in tetrameric 
form. Similar conclusion was drawn for the other mutants investigated.  
7
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Figure 6. Molecular weight determination of phosphorylated and non-phosphorylated 
L-PK by using FPLC and the following molecular weight markers: myoglobulin, 
ovalbumin, bovine serum albumin, immunoglobulin, catalase and ferritine. 
 
 
4.7. Assay of L-PK activity 
Activity of L-PK was measured spectrophotometrically, adopting the procedure 
described before (Fuji & Miwa, 1987). Initial velocities v of the enzyme 
reaction were determined at various concentrations of substrates based on 
coupling of the L-PK catalysed reaction of ATP synthesis with the LDH-
catalysed NADH oxidation. So firstly, L-PK catalyses the formation of pyruvate 
and ATP. Secondly, the pyruvate formed in this reaction is used by LDH to 
form L-lactate simultaneously converting NADH into NAD+. This NADH 
consumption can be followed spectrophotometrically, as absorbance of the 
solution strongly decreases (Δε = 6220 L/cm·mol, =340 nm). To use this 
method the rate of the second process, if compared with the L-PK catalytic 
reaction, must be much faster. This issue was checked by using different LDH 
concentrations at similar conditions of the L-PK catalysis, and no change in the 
apparent velocity of the L-PK catalysed reaction was observed. 
Kinetic measurements of the initial velocity of the catalysis were made at 
30ºC in 1 cm thermostated quartz cells at λ =340 nm using a UV-VIS Unicam 
UV300 spectrophotometer (ThermoSpectronic, USA). The time-course of the 
reaction was monitored for 1–3 min. using a sampling interval of 1 s, 
integration time 0.25 s. The reaction was initiated by the addition of 40 μl of  
L-PK solution into 0.960 ml of the reaction mixture. 
The assay medium in 50 mM TRIS/HCl buffer (pH 7.5, 30ºC) contained: 
0.2 mM NADH, 0.002 mg/ml (1.5 units/ml) LDH, 100 mM KCl, 10mM MgCl2, 
0.1% BSA, 0.1 mM DTT, 0.148 mg/l L-PK. Substrate concentrations varied 
from 0.01 mM up to 10 mM in the case of PEP and from 0.01 mM to 6 mM of 
ADP.  
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Before kinetic assays, enzyme stability was analysed in the assay buffer 
without substrates and no denaturation was observed during 3 min., the same 
time interval used for the kinetic assay. 
 
 
4.8. Processing of kinetic data 
The initial velocities (v) of L-PK reaction were calculated from the time-course 
of the absorbance (Figure 7). The relationship between the initial velocity and 
L-PK concentration was linear, pointing to the fact that the change of the optical 
density of the assay mixture was caused by the enzymatic reaction (Paper I).  
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Figure 7. Spectrophotometric assay of L-PK activity: at 1 mM ADP and different PEP 
concentrations. 
 
To characterise the catalytic properties of enzymes the dependences of the v 
values upon the concentration of both substrates were analysed and kinetic 
parameters calculated. In routine assays the concentration of one substrate was 
kept constant (v vs. PEP at 1 mM ADP and v vs. ADP at 2 mM PEP), and the 
initial velocities vs. concentration plots for the second substrate were analysed 
by the conventional Hill equation (Segel, 1975; Варфоломеев & Гуревич, 
1999): 
 
  
(4) 
 
where S stands for concentration of the variable substrate, Vapp is the apparent 
maximum rate constant, whose value depends on the concentration and kinetic 
properties of the second substrate, K0.5 characterises the concentration of the 
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variable substrate at v = 0.5 Vapp and n stands for the Hill coefficient, 
characterising the cooperativity of the process. 
In the absence of cooperativity, n = 1, the reaction follows the common 
Michaelis-Menten rate equation (Segel, 1975; Варфоломеев & Гуревич, 
1999):  
 
   
(5) 
 
The same equation was used to process data measured in the presence of FBP or 
peptides in the reaction mixture, and the apparent  values were obtained in 
the case of the inhibition effect:  
 
 
 
 (6) 
 
where [I] stands for inhibitor concentration and Ki for inhibition constant. In 
separate experiments the initial reaction rates v were assayed at 0.8 mM PEP 
and 1 mM ADP concentrations in the presence of various concentrations of FBP 
or peptides and the v vs. I concentration plots were used for calculation of the Ki 
values:  
 
    
(7)
 
 
In the case n = 1 the kinetic data for this bi-substrate reaction were analysed 
together by the following rate equation (Segel, 1975): 
 
 
  
(8)
 
   
In this rate equation E stands for the enzyme and the parameters kcat, KPEP, K´PEP, 
KADP and K´ADP correspond to the following reaction scheme: 
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E
E ADP
E PEP
E ADP PEP E  + Products
kcat
K'PEP*
*
* *
KADP
KPEP K'ADP
 
(9) 
 
where K´PEP = αKPEP , K´ADP = αKADP and α characterizes the randomness of the 
substrate binding sequence. 
Data processing was performed with the non-linear least-squares regression 
analysis method by using GraphPad Prism version 4.0 (GraphPad Software Inc., 
USA) and Sigma Plot (Systat Software, Inc. SigmaPlot for Windows). The 
values of kinetic parameters were reported with standard errors. 
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5. RESULTS AND DISCUSSION 
5.1. Molecular properties of L-PK expressed in E.coli 
Molecular properties of the expressed enzyme were determined by SDS-PAGE 
electrophoresis (Figure 8) and by using fast protein liquid chromatography 
(FPLC) as shown in Figure 6, and the data obtained were compared with the 
results for the enzyme extracted from the liver tissue. It can be seen in Figure 8 
that the molecular weight of the recombinant L-PK was the same as of the L-PK 
isolated from rat liver and corresponded to the value 56–59 kDa. Further, the 
FPLC analysis demonstrated that the MW value of 245 kDa for the recombinant 
enzyme was in good agreement with the previously reported MW values for the 
tetrameric form of the enzyme (Albe et al., 1990), and were also in agreement 
with the MW value 245,551 Da calculated from the amino acid sequence of the 
L-pyruvate kinase structure (Noguchi et al., 1987; Lone et al., 1986). Taken 
together, these analyses demonstrated that the enzyme existed in tetrameric 
form in the assay buffer.  
 
 
Figure 8. SDS-PAGE gel shows purified recombinant L-type pyruvate kinase (Rec) and 
L-PK isolated from rat liver (Nat). The right lane shows molecular weight markers: 
BSA, bovine liver catalase, ovalbumin and carbonic anhydrase. 
 
Non-phosphorylated proteins were obtained from the used expression system, 
as bacterial cells do not contain protein kinases similar to the eukaryotic AGC 
family. This assumption was confirmed by the fact that the purified protein was 
efficiently phosphorylated by the cAMP-dependent protein kinase catalytic 
subunit and 4 phosphate groups were incorporated into one tetrameric protein 
molecule as seen in Figure 9, as a single serine residue at position 12 of the  
N-terminal domain of each subunit is phosphorylated by this protein kinase  
(El-Maghrabi et al., 1980, 1982; Schworer et al., 1985; Muirhead et al., 1986).  
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Figure 9. Determination of the stoichiometry of the phosphorylation of recombinant rat 
L-PK expressed in E.coli. Samples were phosphorylated until saturation in the presence 
of [-32P]ATP (left panel) and concentration of radioactivity incorporated into this 
protein was compared with concentration of the enzyme (right panel). The slope of the 
linear plot was 3.97±0.09 in agreement with 1:1 stoichiometry of the phosphorylation of 
subunits of the tetrameric enzyme 
 
Phosphorylation of the E.coli-expressed L-PK had no influence on the 
tetrameric structure of this enzyme, as the protein eluted similarly with the non-
phosphorylated L-PK from the Superdex 200 HR 10/30 column (Figure 6).  
Taken together, the enzyme expressed in E.coli was not phosphorylated, and 
it was stoichiometrically phosphorylated in the presence of protein kinase A. 
This phosphorylation reaction had no effect on the molecular properties of the 
protein, as both phosphorylated and non-phosphorylated enzymes existed in 
tetrameric form.  
 
 
5.2. Catalytic properties of L-PK expressed in E.coli 
The non-phosphorylated recombinant enzyme was catalytically active in the 
conventional L-PK assay system and the relationships of the initial rate vs. ADP 
and PEP concentration were determined (Figure 10). It can be seen that the 
obtained plots were hyperbolic, indicating that the non-phosphorylated enzyme 
was not cooperatively regulated by PEP as well as by ADP concentration. 
Therefore, the kinetic data for the non-phosphorylated L-PK were processed by 
rate equation 8, derived for a common bi-substrate enzyme reaction, taking into 
account that K´PEP = αKPEP , K´ADP = αKADP. In this equation the coefficient α 
characterises the randomness of the substrate binding sequence (Segel, 1975), 
and the following results were obtained:  
 
V = 15.8 ± 0.5 μmol/mg·s  
KADP = 0.26 ± 0.03 mM 
KPEP = 0.11 ± 0.02 mM 
α = 0.96 ± 0.10 
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The α value was close to 1 that was in agreement with the random substrate 
binding model.  
 
Figure 10. Comparison of kinetic properties of non-phosphorylated (▲) and 
stoichiometrically phosphorylated (■) L-PK at variable PEP concentrations (left panel, 
ADP concentration 1 mM) and at variable ADP concentrations (right panel, PEP 
concentration 2 mM) in 50 mM Tris-HCl buffer, pH 7.4, 30ºC. 
 
After the recombinant L-PK was stoichiometrically phosphorylated its catalytic 
properties revealed significant changes. It can be seen that PEP binding 
followed sigmoid function, while ADP binding still followed hyperbolic 
dependence (Figure 10). Analysing the kinetic data for phosphorylated L-PK by 
equation 4, K0.5 values for PEP and ADP and also the Hill coefficient for both 
substrates were obtained. These results were as follows: 
 
For PEP:  K0.5 = 2.2 ± 0.1 mM  n = 2.5 ± 0.2 for PEP
For ADP: K0.5 = 0.11 ± 0.01 mM  n = 1.1 ± 0.2, for ADP
  
Taken together, these kinetic data demonstrated that phosphorylation lowered 
the affinity of the enzyme for PEP, while it had no effect on the affinity of the 
enzyme for the second substrate ADP. This asymmetric influence was in good 
agreement with all previously published works (El-Maghrabi et al., 1980; 
Schworer et al., 1985). However, in parallel with this change, phosphorylation 
also changed the cooperativity of the system. 
For further analysis of the cooperativity of phosphorylated L-PK toward PEP 
we used the sequential substrate binding model. Positive cooperativity assumes 
that binding of one PEP molecule to multimeric enzyme affects binding 
properties of the remained subunits (Koshland & Neet, 1968). For simpli-
fication of the model we considered that the presence of another substrate, ADP, 
has no effect on PEP binding. So the interaction of PEP with 4 subunits in the 
tetrameric enzyme can be presented by the following reaction scheme:  
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K kE + S ES E + products  (10) 
K kES + S ES ES + products
2

  (11) 
K kES + S ES ES + products
2 3 2

  (12) 
K kES + S ES ES + products
3 4 3

   
(13) 
 
where E stands for enzyme and S is substrate (PEP). The substrate interaction 
with the first enzyme subunit is quantified by the dissociation constant K, 
affinity for the second substrate molecule is quantified by αK, affinity for the 
third and fourth substrate molecules by βK and γK, respectively. So α, β and γ 
characterise the interactions between the enzyme subunits. 
The probability factors must be also considered, as in the case of the 
tetrameric enzyme there are four ways to form an ES complex from E, six ways 
to form the complex ES2 from ES, four ways to form ES3 from ES2 and one way 
to form ES4 from ES3. Taking into account these probability factors, and 
assuming that all complexes are in equilibrium, the following rate equation 14 
can be obtained for the cooperatively functioning tetrameric enzyme (Segel, 
1975): 
 
       
       
2 3 4
2 2 3 3 4 4
2 3 4
2 2 3 3 4 4
S 3 S 3 S S
K K K Kv V
4 S 6 S 4 S S
1
K K K K
    
     
 (14) 
 
In this equation V is determined by the total amount of the active sites, in the 
case of tetrameric enzyme 4 times bigger than the analytical enzyme 
concentration (Eq. 15): 
 
 MAX totalV 4k E (15) 
 
Using equation 14, the cooperativity of L-PK was characterised by α, β and γ 
parameters, comparing the affinity of the binding steps: 
α = 1.0 
β = 0.1 
γ = 0.1 
 
 
9
34 
As α = 1, binding of the first substrate molecule had no influence on the binding 
of the second substrate. But for binding of the third substrate molecule the 
affinity of the enzyme increased. The same increase was also observed in the 
case of the fourth PEP molecule. This means that binding of the first two 
molecules increases the affinity of the enzyme for binding the next two 
substrates, as assumed in the cooperativity model describing the tetrameric 
molecule as the “dimer of dimers” (Fenton & Hutchinson, 2009). 
 
 
5.3. Kinetics of phosphorylation of expressed L-PK 
The time course of phosphorylation of non-phosphorylated L-PK by PKA is 
shown in Figure 11. It was found that the phosphorylation reaction followed the 
exponential rate equation: 
 
Ct = C∞ exp (-kobst) + C0 (16) 
 
where Ct stands for radioactivity incorporated into the protein at time moment t, 
C∞ is the maximum amount of protein-bound radioactive phosphorus, C0 stands 
for background of the bound radioactivity and kobs is the observed rate constant 
of the reaction. Under the experimental conditions used in this work, the level 
of the non-specifically bound radioactivity C0 was small if compared with the 
specifically bound radioactivity C∞, and therefore the C∞ value, calculated from 
the kinetic curve in Figure 11 agreed well with the experimental “plateau” 
values of the phosphorylation reaction shown in Figure 9. 
 
Figure 11. Kinetic analysis of the phosphorylation of L-PK expressed in E.coli by the 
cAMP dependent protein kinase catalytic subunit in the presence of 100 µM -[32P]ATP, 
30C, 50 mM TRIS/HCl buffer (pH 7.5). The time-course of incorporation of 
radioactivity into protein (Ct) was approximated by exponential function and the linear 
transform of this plot was shown in intercept. 
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The exponential rate equation 16 refers to the pseudo-first-order conditions of 
the phosphorylation reaction, where the substrate (L-PK) concentration is small 
and remains below the K0.5 value for this substrate. Therefore, the observed rate 
constants kobs calculated from the kinetic curves in Figure 9 (left panel) were 
similar and yielded the mean kobs value 0.29 ± 0.05 min.–1. Moreover, the 
conclusion about the pseudo-first-order conditions was also supported by the 
statistically relevant linear plot between the initial rate values of the L-PK 
phosphorylation reaction the substrate (L-PK) concentration. And finally, the 
conclusion was in agreement with the K0.5 value 17 μM estimated for the L-PK 
phosphorylation reactions by PKA as was shown by Pilkis et al., 1980.  
Taken together, the kinetic data indicated that all four phosphorylatable sites 
of the tetrameric protein structure were phosphorylated randomly, and the 
phosphorylation of one subunit did not affect the phosphorylation of the 
following subunits.  
 
 
5.4. Interrelationship between phosphorylation and 
cooperativity 
The regulatory phosphorylation reaction occurs at the S12 residue of the N-
terminal part of L-PK (Mattevi et al., 1996; Muirhead et al., 1986), and protein 
extracted from liver tissue contained 2–3.5 moles of phosphate per tetrameric 
enzyme molecule (El-Maghrabi et al., 1980, 1982; Pilkis et al., 1980; Berglund 
et al., 1977). Therefore, additional phosphorylation of the enzyme was possible 
and this caused a decrease of the PEP binding affinity and led to a change in the 
sigmoid shape of the initial velocity vs. PEP plots. Formally this change 
resulted in higher values of the Hill coefficient n in Eq. 4 (El-Maghrabi et al., 
1980, 1982; Schworer et al., 1985).  
For example, the enzyme extracted from the liver contained 3 moles of 
phosphate per mole of tetrameric L-PK and was characterised by  
KPEP = 1.15 mM and n = 2.0 (El-Maghrabi et al., 1980). Complete 
phosphorylation of this enzyme raised the KPEP value up to 1.4 mM and 
increased the n value up to 2.2 (El-Maghrabi et al., 1980). In another study, 
KPEP =1.1 mM and n = 2.5 were reported for the completely phosphorylated 
enzyme (Schworer et al., 1985). And finally, KPEP = 2.2 mM and n = 2.5 were 
obtained for the stoichiometrically phosphorylated enzyme in this study.  
Partial dephosphorylation of the enzyme, leaving approximately 1 mole 
phosphate per tetrameric L-PK molecule, decreased the KPEP value to 0.6 mM 
(El-Maghrabi et al., 1980) and resulted in a shallow Hill plot characterised by  
n = 1.8. The latter value was calculated by Eq. 4 from data published by  
El-Maghrabi et al. (El-Maghrabi et al., 1980). Analogously, KPEP = 0.55 mM 
and n = 1.5 were obtained from data published by Schworer et al. (Schworer et 
al., 1985).  
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All these results clearly point to the presence of an interrelationship between 
the L-PK affinity for PEP and the level of phosphorylation of this protein, and 
also between the Hill coefficient n and the phosphorylation level. Both of these 
dependences are shown in Figure 12.  
The results in Figure 12 demonstrate that phosphorylation can be specified 
as a “switch” between cooperative and non-cooperative forms of L-PK. This 
conclusion supports the suggestion made by Muirhead in 1990 (Muirhead, 
1990) that the N-domain of L-PK may have a functional role in the transmission 
of allosteric structural changes in pyruvate kinases. Later, a significant role of 
the N-terminus of L-PK in allosteric control of activity of this enzyme was also 
suggested by Fenton and Tang (Fenton & Tang, 2009).  
 
Figure 12. Dependence of the L-PK affinity for PEP (pKPEP) (left panel) and plot of the 
Hill coefficient (n) for PEP binding with L-PK (right panel) upon the level of L-PK 
phosphorylation. 
 
The plot obtained for Hill coefficients revealed that a clear change in coopera-
tivity accompanied the phosphorylation of a single subunit in the tetrameric 
structure, as this modification increased the n value from 1 to 2, while the 
following phosphorylation of other sites increased the n value up to 2.2 or 2.5. 
However, phosphorylation of the second, third and fourth subunits still 
decreased PEP binding effectiveness, while a more than 10-fold difference can 
be observed between the KPEP values of the non-phosphorylated and the 
stoichiometrically phosphorylated enzyme. In parallel with these major changes 
in PEP binding, ADP binding was practically not affected by phosphorylation. 
It should be emphasised that the experimentally determined value of the 
phosphorylation level of L-PK reflects only the average overall stoichiometry, 
while the relative abundances of the enzyme molecules carrying one, two, three 
or four phosphate groups are determined by the kinetic mechanism of the 
reaction. This mechanism can be specified proceeding from the fact that the 
time course of the overall reaction was well described by a single exponential 
function. This result can be explained by two distinct kinetic models.  
Firstly, it is possible that the whole population of phosphorylation sites is 
homogeneous and all four subunits of the L-PK molecule are phosphorylated 
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independently and at equal rates. This means that formation of the enzyme 
molecules carrying one, two, three or four phosphate groups is a consecutive 
process, and the mono-phosphorylated tetramers should prevail at the beginning 
of the process. 
Secondly, however, the same exponential time course of phosphorylation 
can be explained by the rate-limiting phosphorylation reaction at the first 
subunit and fast phosphorylation of the other subunits of the tetrameric protein. 
Following this model, phosphorylation of ¼ of the sites means that ¼ of L-PK 
molecules are fully phosphorylated, while the rest are not phosphorylated. In the 
latter case the resulting initial velocity versus the PEP concentration plot should 
be a sum of hyperbolic and sigmoid plots, where the hyperbolic impact of the 
non-phosphorylated enzyme would influence the shape of the curve up to 
relatively high mole-per-mole phosphate levels. Such abnormality of the shape 
was not observed in previous studies. 
In contrast, in the case of the random phosphorylation of equal sites the 
entirely non-phosphorylated form should disappear relatively fast, and as 
cooperativity is concurrent with the addition of the first phosphate per tetramer, 
the initial velocity versus the PEP curve becomes non-hyperbolic at early stages 
of phosphorylation.  
Taken together, phosphorylation of the N-terminal peptide of L-PK initiates 
cooperativity of the enzyme towards PEP concentration, and this mechanism is 
most probably switched on by the addition of the first phosphate of the four, 
needed for the stoichiometric phosphorylation of the tetrameric protein. 
 
 
5.5. Interrelationship between N-domain structure and 
activity of L-PK 
On the phenomenological level, the dependence of L-PK activity upon 
phosphorylation was described in 1974 (Ljungström et al., 1974, Ekman et al., 
1976). Further, it was observed that the enzyme activity could be decreased by 
limited proteolysis of the N-terminal peptide (Bergström et al., 1978). The 
recent study of proteolytic truncation of the N-terminal part confirmed these 
results, demonstrating that removal of amino acids in positions from 7 to 12 
reduced PEP binding effectiveness (Fenton & Tang, 2009). Thus truncation and 
phosphorylation seem to have a rather similar influence on L-PK binding 
properties. 
On the basis of truncation experiments it has been suggested that the  
N-terminal peptide of L-PK might interact with the main body of this protein, 
inducing in this way the active state of the enzyme. Correspondingly, 
interruption of this interaction by truncation of the N-terminal peptide should 
convert the enzyme into the low affinity state against PEP (Fenton & Tang, 
2009). Interestingly, the possibility of such internal equilibria and their role in 
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regulation of enzyme activity was already discussed in general terms by 
G. Weber in 1972 (Weber, 1972).  
As the amino acids, whose removal affects PEP binding effectiveness, are 
located before the phosphorylation site on S12, we decided to probe the 
functioning of the L-PK regulatory phosphorylation site by point mutations in 
positions 9, 10 and 13, and alanine, leucine, lysine, glutamine and glutamic acid 
were introduced into these positions (Table 1), changing apropos the ionic 
charge of this domain, and thus indirectly simulating a change of the ionic 
status of the N-domain peptide, as happens in the case of phosphorylation. 
All these mutants were able to catalyse the synthesis of ATP and their 
catalytic properties were characterised by the initial rate vs. PEP concentration 
plots at 1 mM ADP concentration, and by similar plots for different ADP 
concentrations at 2 mM PEP. The data obtained for both substrates were 
analysed by rate equation 4, which allowed calculation of the apparent affinity 
constant K0.5 and the Hill coefficient n. The results of these calculations are 
listed in Table 1. It can be seen from these data that the Hill coefficient was 
equal to 1 for all mutants, pointing to the fact that the interaction of PEP and 
ADP with these enzymes was not cooperatively regulated. In other words, the 
dependence of the initial velocity upon substrate concentration was well 
described by the common hyperbolic rate equation, and this fact is illustrated in 
Figure 13 where the consolidated kinetic data for L-PK mutants are shown.  
 
Table 1. 
L-PK  
N-terminal 
domain fragment 
kcat 
µmol/mg*sec , mM , mM n for PEP n for ADP 
L-PK Mutants   
-ARAS12VA- 12,0±0.2 0.19±0.03 0.24±0.05 0.9±0.1 0.9±0.1 
-KRAS12VA- 09.5±0.2 0.32±0.05 0.24±0.04 0.6±0.1 1.0±0.1 
-ERAS12VA- 14.2±0.7 02.3±0.40 0.20±0.06 0.9±0.1 0.9±0.3 
-QRAS12VA- 13.6±0.2 0.39±0.08 0.27±0.04 0.90.1 0.9±0.1 
-RAAS12VA- 13,1±0.4 0.18±0.04 0.33±0.08 1.0±0.1 1.0±0.1 
-RKAS12VA- 09.1±0.3 0.17±0.04 0.33±0.06 0.7±0.1 1.0±0.1 
-RQAS12VA- 15,5±1.0 0.31±0.06 0.33±0.03 1.10.1 0.9±0.1 
-RLAS12VA- 11,6±0.2 0.29±0.07 0.21±0.03 1.20.3 1.0±0.1 
-RRAS12AA- 15,6±0.2 0.19±0.03 0.31±0.05 1.0±0.1 1.0±0.1 
-RRAS12EA- 15,2±0.5 0.22±0.04 0.27±0.05 1.0±0.1 1.1±0.1 
Wild type non-phosphorylated L-PK   
-RRAS12VA- 15.8±0.5 0.11±0.02 0.28±0.02 1.1±0.1 1.1±0.1 
Wild type phosphorylated L-PK   
-RRAS12(Pi)VA- 09.6±0.7 02.2±0.10 0.11±0.01 2.5±0.2 1.1±0.2 
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Figure 13. Effect of PEP and ADP concentration on the rate of ATP synthesis catalysed 
by L-PK and its mutants. The following enzymes were used: non-phosphorylated L-PK 
(); phosphorylated L-PK (●); L-PK mutants R9E (○); R9K (◊); R9A (■); R9Q (□); 
R10Q (+); R10L (♦); R10A (); R10K (); V13A (); V13E ().  
 
It can be seen in Table 1 that mutations made in the regulatory part of L-PK had 
a different influence on the interaction of ADP and PEP with the enzyme. As 
the  values were similar in the case of all mutants, and were also close to 
the same parameter for the wild type of non-phosphorylated and phosphorylated 
L-PK, it can be concluded that the binding site of this substrate was not affected 
by these mutations. On the other hand, however, some mutations affected the 
enzyme affinity for PEP, and this effect was clearly dependent upon the 
structure of the introduced amino acids. If smaller shifts in the  values 
were observed with mutants R9Q, R9K, R10Q and some others, this effect was 
large when arginine residues were replaced by glutamic acid. It can be seen 
from Table 1 that this mutation (R9E) increased the  value more than 20-
fold, and again, without any effect on ADP binding.  
In summary, some mutations in the N-terminal domain of L-PK specifically 
affected the PEP binding site, and the effect was dependent on the nature of the 
inserted amino acid. Differently from PEP, the binding of ADP was not 
influenced by the same mutations.  
It is noteworthy that a similar asymmetric change of the catalytic properties 
of L-PK was also caused by phosphorylation, as this modification significantly 
decreased the enzyme affinity for PEP and had practically no effect on ADP 
binding (Table 1). From this point of view, mutations made in the N-terminal 
domain of L-PK and phosphorylation of this domain had a similar influence, 
and could be correlated with the ionic status of the N-terminal domain of L-PK, 
governed by two arginine residues in positions 9 and 10. Replacement of one 
arginine with glutamic acid changed the net charge of the regulatory domain by 
–2 charge units. A similar change was also caused by phosphorylation, pointing 
to the possibility that the L-PK affinity for PEP could be governed by 
electrostatic interactions.  
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The ionic status of the regulatory domain was also affected by other 
mutations. For example, the number of positive charges of the N-domain was 
changed by –1 charge unit in mutants, where non-ionic amino acids alanine, 
leucine and glutamine were used to substitute the arginine residue in position 9 
or 10. The same change in the ionic status of the regulatory N-domain was also 
achieved by replacement of the non-ionic valine 13 by glutamic acid. It can be 
seen from Table 1 that all these replacements had a relatively low impact on the 
enzyme affinity for PEP. On the other hand, if arginine was replaced by lysine 
there was no change in the net charge of the regulatory domain, but still the 
effectiveness of PEP binding was changed. Consequently, the binding 
effectiveness of PEP cannot be unequivocally linked with the ionic charge of 
the N-terminal part of the protein.  
The activity of the phosphorylated L-PK was cooperatively regulated by 
PEP and this effect was characterised by the Hill coefficient n = 2.5. At the 
same time the mutant R9E, as well as other mutants studied, revealed no 
cooperative feedback and the appropriate kinetic data were adequately 
described by the Hill coefficient 1 (Table 1). Therefore, the down-regulation of 
enzyme affinity for PEP and switching on cooperativity for this substrate should 
be governed by two different mechanisms. However, in both these mechanisms 
the regulatory pattern has remained asymmetric for PEP and ADP. 
 
 
5.6. Asymmetric regulation of PEP and ADP binding 
The fact that phosphorylation of the N-domain of L-PK and the point mutations 
(R9E) had an asymmetric influence on ADP and PEP binding indicated that the 
appropriate changes made in the regulatory domain should differently affect the 
binding sites of these substrates. Indeed, it has been described that binding of 
these substrates occurred in somewhat different areas of the enzyme molecule 
(Munoz & Ponze, 2003; Mattevi et al., 1996; Jurica et al., 1998; Muirhead et al., 
1986). However, the binding sites of both substrates are still in the same domain 
of the protein and remain close to each other. Moreover, the close location of 
the enzyme-bound ADP and PEP is also required for the direct transfer of the 
phosphate group from PEP to ADP in the chemical step of the catalysis 
(Muirhead et al., 1986).  
We carried out computer modelling of ADP and PEP docking with the L-PK 
subunit. The model of this protein (Figure 14) was built up proceeding from 
structural data for the R isozyme (Valentini et al., 2002) and omitting 25 amino 
acids of the flexible N-terminal domain, as this structure was not determined by 
X-ray analysis. The position of the amino acid number 26 is shown by the arrow 
in Figure 14. One bivalent (Mg2+) and one monovalent (K+) cation, depicted by 
the yellow and violet spheres in Figure 14, were included in the protein model. 
Positioning of these ions should define the location of the catalytic site of L-PK, 
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as their participation is important for the phosphoryl transfer reactions 
(Muirhead et al., 1986). Therefore, it was not surprising that the calculated 
docking sites for ADP and PEP labelled the same area of the protein molecule 
as illustrated in Figure 14.  
 
 
Figure 14. Computer modelling of PEP (left) and ADP (right) docking with the L-PK 
subunit. The protein model was built up starting from amino acid no. 26 (shown by the 
arrow), as the coordinates of preceding amino acids have not been determined due to 
significant flexibility of this part of the protein. The locations of Mg2+ (yellow sphere) 
and K+ (violet sphere) were shown in the catalytic site. Three energetically close 
docking poses were shown for each substrate and the bold structure referred to the best 
complex. The atoms of the ligands were marked as follows: carbon – black, oxygen – 
red, nitrogen – blue, and phosphorus – brown. 
 
The computer modelling of ligand docking yielded several possible complexes 
that were ranked by the values of binding energy. It can be seen from Figure 14 
that the binding poses obtained for both substrates marked quite definitely the 
catalytic site of the enzyme, while the most stable complexes from this list were 
shown in bold. Certainly, further calculations should be made to obtain the 
more precise structure of these complexes, also considering the dynamics of the 
protein molecule (Totrov & Abagyan, 2008), and inter-subunit interactions. 
However, even the present tentative docking model confirms the close 
positioning of PEP and ADP in the active centre of L-PK (Figure 14). 
The N-terminal regulatory domain of L-PK is located at a considerable 
distance from the substrate binding sites, but still its phosphorylation at S12, as 
well as introduction of mutations in positions 9, 10 and 13, altered the binding 
11
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effectiveness of PEP with the enzyme. This regulation could not be explained 
by the conventional structural models of allostery, as these models assume 
transfer of conformational changes from the regulatory site to the substrate site 
by changing interactions between certain pairs (or sets) of amino acids, 
implying a trimmed and even somewhat strained protein structure. This regular 
structure is missing in the case of the N-domain of L-PK. Therefore, the 
transition of the regulatory effects to the active site of L-PK, and its targeted 
manifestation in the case of only one substrate, seems to define some alternative 
mechanism of allosteric control.  
This mechanism could be based on the noticeable flexibility of the 
regulatory N-domain, as was initially proposed in (Bergström et al., 1978), and 
further discussed in (Fenton & Tang, 2009). Notoriously, this hypothesis agreed 
well with the results of probing the L-PK phosphorylation site by mutational 
analysis, as different degrees of the regulatory effect were achieved. Following 
this hypothesis it was suggested that the flexible N-terminal peptide of L-PK 
could, indeed, bind to the main body of the protein and this interaction was 
assumed to be responsible for high-affinity PEP binding. Truncation, 
phosphorylation and mutation of the N-terminal regulatory domain seem to 
interfere with this interaction and reduce the enzyme affinity for PEP.  
 
 
5.7. Interaction of FBP and model peptides  
resembling the N-terminal domain of L-PK  
with the non-phosphorylated enzyme 
Firstly, it was investigated whether the activity of the non-phosphorylated L-PK 
could be regulated by FBP, and the activity of the enzyme was monitored in the 
presence of this ligand. These results revealed no activation, but slight 
reversible inhibition, characterised by the Ki value 24 ± 3 μM was observed 
(Figure 15). Most interestingly, inhibition of the L-PK catalysed reaction by the 
excess of FBP has also been observed in earlier studies using L-PK extracted 
from rabbit liver (Irwing & Williams, 1973). However, as in this case the 
phosphorylated enzyme was also activated by FBP, and the observed depen-
dence of the reaction rate versus FBP concentration was characterised by the 
sum of activation and inhibition effects. Therefore, the inhibition effect was 
seen after the activation effect had levelled off. Thus the inhibition phenomenon 
seems to be similar in the case of the phosphorylated and non-phosphorylated 
enzymes, and probably demonstrates that FBP may also compete for the PEP 
binding site, as both ligands have phosphate groups recognised by the active site 
of L-PK. 
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Figure 15. Influence of 60μM FBP ( ○ ) and 100 μM phosphopeptide RRAS(Pi)VA 
( ☐ ) on the catalytic properties of the non-phosphorylated L-PK at different PEP 
concentrations (● – control curve). Both these ligands did not induce cooperativity of 
the enzyme, but revealed slight inhibition of the reaction. 
 
Secondly, the interaction of non-phosphorylated L-PK with short peptides that 
mimic the phosphorylatable N-terminal domain of the enzyme was studied. We 
used peptide RRASVA, which corresponds to fragments 9–14 of the L-PK  
N-domain, and RRAAVA, which corresponds to the point-mutated 
phosphorylatable peptide. It was found that neither of these peptides influenced 
the activity of non-phosphorylated L-PK (Figure 16), while similar peptide 
fragments enhanced PEP binding with the L-PK mutant resembling the 
phosphorylated enzyme (Prasannan et al., 2012).  
 
Figure 16. Influence of peptides RRASVA (Δ), RRAAVA (▼) and phosphorylated 
peptide RRAS(Pi)VA ( ☐ ) on the activity of the non-phosphorylated L-PK. 
Concentrations of ADP and PEP in the assay mixture were 1.0 mM and 0.8 mM, 
respectively. 
 
44 
Finally, the influence of the phosphorylated peptide RRAS(Pi)VA on the 
catalytic properties of non-phosphorylated L-PK was studied. It was found that 
in the presence of 0.4 mM phosphopeptide a slight shift of PEP binding 
effectiveness was observed. The meaning of this phenomenon is more clearly 
demonstrated in Figure 16, where data about inhibition of the non-
phosphorylated L-PK by RRAS(Pi)VA, characterised by the Ki value 47±7 μM, 
were shown. On the other hand, the ligand RRAS(Pi)VA did not induce 
cooperativity of the enzyme against PEP, although the initial purpose of this 
experimental set-up was to analyse this possibility.  
Taken together, the present results demonstrate that the non-phopshorylated 
L-PK is not an allosterically regulated enzyme, and all allosteric regulation 
mechanisms known in the case of the phosphorylated L-PK should be switched 
on through phosphorylation of the regulatory N-terminal peptide of this protein. 
On the other hand, both phosphorylated ligands, FBP and RRAS(Pi)VA, 
revealed an inhibitory effect, which was probably connected with competition 
of these molecules with PEP for its binding site in the active site of the enzyme.  
 
 
5.8. Putative docking site for the N-domain  
peptide on the main body of protein 
The hypothesis that there may be a specific binding site for the N-terminal 
peptide on the main body of L-PK was probed by a computer simulation of 
docking of specific peptides: RRASVA and ERASVA, resembling the 
phosphorylation site of the wild-type enzyme and of its mutant R9E, 
respectively. Moreover, the phosphorylated peptide RRAS(Pi)VA was also used 
for the docking study. However, several energetically and geometrically 
different binding poses were obtained for each of these peptides. In all cases the 
most efficient poses were clearly grouped within the same region of the protein 
surface, thus labelling their most probable binding site.  
It can be seen in Figure 17 that binding of RRASVA occurred close to the 
active centre of the enzyme. Interestingly, the docking site for the peptide 
ERASVA, which corresponds to the regulatory domain of the R9E mutant, was 
also located in the same region. Moreover, similar results were obtained for 
other mutant peptides. Therefore, these peptides could indeed govern PEP 
binding, while the effectiveness of this influence should be dependent upon 
their amino acid composition. The absence of a similar influence on ADP 
binding can be explained by stronger “anchoring” of this substrate in the active 
centre, perhaps via the protein-bound magnesium ion, as the stability of the 
ADP-Mg complex characterised by the pKdiss value 3.7 (Belaich & Sari, 1969) 
exceeds the stability of the PEP-Mg complex characterised by pKdiss=2.2 (Wold 
& Ballou, 1957).  
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Figure 17. Computer modelling of docking of peptide fragments RRASVA (left), 
ERASVA (centre) and phosphopeptide RRAS(Pi)VA (right) with the L-PK subunit. 
The protein model described in Figure 14 was used. The docking poses of the lowest 
energy were shown for each peptide. Atoms of the ligands were marked as follows: 
carbon – black, oxygen – red, nitrogen – blue, and phosphorus – brown. 
 
On the other hand, however, the phosphorylated peptide RRAS(Pi)VA clearly 
preferred a different binding site located outside the enzyme active centre 
(Figure 17). This means that phosphorylation should shift this peptide from one 
binding site into another, which is located close to the C domain. If a similar 
shift takes place in the case of the enzyme molecule, this structural transition 
could function as a switch for L-PK cooperativity.  
This second docking site was partially overlapping with the binding site for 
the allosteric regulator FBP (Munoz & Ponze, 2003; Mattevi et al., 1996; Jurica 
et al., 1998). Following the results of this docking study, the allosteric effect of 
this ligand may be explained by competition between the phosphorylated  
N-terminal peptide and FBP for the second binding site on domain C, as 
displacement of the phosphorylated N-domain peptide from this site by FBP 
may restore the structural requirements for effective PEP binding. However, 
further discussion of the structural and mechanistic aspects of L-PK regulation 
by phosphorylation needs more thorough modelling, taking into account the 
protein dynamic properties and inter-subunit interactions within its tetrameric 
structure. 
12
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6. CONCLUDING REMARKS 
Among the four pyruvate kinase isoenzymes, denoted as M1, M2, R and L, only 
M1 reveals no cooperativity against phosphoenolpyruvate (PEP) concentration. 
However, here we show that the non-phosphorylated form of L-type pyruvate 
kinase (L-PK) is also a non-cooperative enzyme against PEP, while the 
cooperativity and other allosteric catalytic properties of this enzyme are 
switched on through phosphorylation of this protein by cAMP-dependent 
protein kinase. The level of cooperativity of the enzyme, characterised by the 
Hill coefficient, depends on the phosphorylation stoichiometry, but the 
allosteric mechanism as such is engaged by phosphorylation of the first subunit 
of the tetrameric enzyme, and further phosphorylation only modulates this 
effect. The discovered switching between non-allosteric and allosteric forms of 
this enzyme and the possibility of modulating the allostery by phosphorylation 
seems to be important for understanding the interrelationship between allostery 
and the regulatory phosphorylation phenomenon in general, and may also have 
some implication for further analysis of the regulation of glycolysis in the liver. 
Cooperativity of the non-phosphorylated L-PK cannot be induced in the 
presence of peptides that mimic the phosphorylated or non-phosphorylated  
N-domain sequence of the protein, and also by the introduction of additional 
negative charges to the protein structure around the phosphorylatable serine 
residue in the protein regulatory domain. At the same time these variations in 
protein structure may influence the enzyme affinity for PEP, pointing to the 
possibility that the regulatory domain may interact with the protein main body 
and thereby govern the enzyme activity, as was initially suggested by A. Fenton 
and Tang (Fenton & Tang, 2009). We have also identified that the docking site 
of the N-domain may well be in the region of the PEP binding site and thus this 
interaction may support PEP binding. Phosphorylation obviously hinders 
formation of this intramolecular complex and therefore reduces PEP binding 
effectiveness. The stability of this complex also seems to be affected by 
mutations in the N-domain peptide and shifting this equilibrium could explain 
the alteration of PEP binding effectiveness with the mutant enzymes. However, 
differently from phosphorylation, the cooperativity of the enzyme cannot be 
switched on by these mutations.  
Some structural aspects of L-PK regulation were discussed proceeding from 
the results of mutation analysis and computer modelling of binding of the 
regulatory domain fragments with the main body of the enzyme. These results 
demonstrate that the cooperativity and allosteric properties of L-PK seem to be 
governed by some additional mechanism. Most likely it is based on the mutual 
competition of FBP and the phosphorylated N-domain for the same binding site 
on the C subunit of the enzyme. 
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7. SUMMARY 
Pyruvate is an essential substrate in metabolic processes, and regulation of the 
activity of pyruvate kinases is essential for control over the energy and carbon 
fluxes in living cells. In liver tissue, where both of these glycolysis and 
glyconeogenesis pathways are in function, the tissue-specific pyruvate kinase 
(L-PK) is activated homotropically by phosphoenolpyruvate (PEP) and 
heterotropically by fructose-1,6-bisphosphate (FBP), and both of these effects 
depend on phosphorylation of the N-terminal domain of the enzyme. In this 
dissertation the regulatory role of the N-terminal domain has been studied by 
using conventional methods of protein chemistry and chemical kinetics along 
with computational ligand docking analysis. 
The results of this study revealed that the activity of the non-phosphorylated 
L-PK was characterised by a common hyperbolic Michaelis-Menten plot in the 
case of PEP (KPEP = 0.11 mM) and the activity of the enzyme was not regulated 
by FBP. The cooperativity of the enzyme for PEP was switched on by 
phosphorylation of the protein by cAMP-dependent protein kinase. The 
stoichiometrically phosphorylated enzyme, containing four moles of phosphate 
per tetrameric L-PK molecule, was characterised by KPEP = 2.2 mM and the Hill 
coefficient n = 2.5. It was also observed that enzyme cooperativity was mostly 
engaged by phosphorylation of the first subunit in the tetrameric protein, while 
further phosphorylation only modulated this effect. Further, it was found that 
the activity of the non-phosphorylated L-PK was not elevated by FBP, and this 
ligand acted as a relatively weak reversible inhibitor. As the phosphorylated  
L-PK is a subject of significant allosteric activation by FBP, it was concluded 
that phosphorylation should also function as a molecular switch in the case of 
the allosteric properties of L-PK.  
The regulatory phosphorylation occurs in the serine residue in position 12 of 
the N-terminal sequence MEGPAGYLRR10AS12VAQLTQEL20GTAFF, and in 
this study the influence of point mutations around the phosphorylation site in 
positions 9, 10 and 13 on the catalytic properties of the mutants was studied. 
Amino acids A, L, Q and E were introduced into these positions to alter the net 
charge of the regulatory domain and to check whether redistribution and/or 
introduction of new ionic groups can mimic the effect of serine phosphorylation. 
It was found that some of these mutations affected the catalytic activity of the 
enzyme by reducing the effectiveness of phosphoenolpyruvate binding, 
simulating thus the effect of regulatory phosphorylation. This result was in 
agreement with the ideas suggested by A. Fenton & Tang (Fenton & Tang, 
2009) that the flexible N-domain may interact with the main body of the 
enzyme affecting substrate binding, and this interaction is interfered with by 
phosphorylation. However, differently from phosphorylation, the cooperativity 
of the enzyme was not switched on by these mutations in the N-domain. 
Finally, following the suggestion that the N-domain interacts with the main 
body of the L-PK molecule, computational analysis was made to identify 
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putative binding sites. The docking site of the N-domain peptide RRASVA was 
found in the vicinity of the enzyme active centre, while docking of the 
phosphorylated analogue RRAS(Pi)VA occurred on the C domain of the L-PK 
molecule, in a site overlapping with the allosteric site for FBP binding. This 
means that formation of these intramolecular complexes may indeed change 
equilibrium between the active R-state and the less active T-state of the enzyme, 
while induction of cooperativity by the N-domain phosphorylation could be 
connected with phosphopeptide intramolecular binding with the enzyme 
allosteric site.  
The phenomenon of switching between non-allosteric and allosteric forms of 
L-PK and the possibility of modulating of the enzyme allostery by 
phosphorylation may have some implication for further understanding of the 
regulation of glycolysis in the liver. 
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8. SUMMARY IN ESTONIAN 
L-tüüpi püruvaadi kinaasi N-terminaalse  
domeeni regulatoorne roll 
Püruvaat on oluline metabolismi substraat ja seetõttu on püruvaadi kinaaside 
aktiivsuse regulatsioon oluline raku energia- ja süsinikuvoogude suunamise 
seisukohast. Maksas, kus samaaegselt toimivad need mõlemad metabolismi 
rajad, esineb koe-spetsiifiline püruvaadi kinaaas (L-PK), mis on aktiveeritud 
homotroopselt selle ensüümi substraadi fosfoenoolpüruvaadi (PEP) poolt ning 
heterotroopselt fruktoos-1,6-bisfosfaadi (FBP) poolt. Samas on need mõlemad 
efektid omakorda reguleeritud selle ensüümi N-terminaalse domeeni fosfo-
rüleerimise kaudu. Käesolevas töös uuriti selle regulatoorse fosforüleerimise 
nähtuse tagamaid, kasutades selleks klassikalisi valgukeemia meetodeid ning 
keemilise kineetika rakendusi koos ligandide seostumise modelleerimisega 
arvutil.  
Töö tulemused näitasid, et mitte-fosforüülitud L-PK poolt katalüüsitud reakt-
sioon on PEP korral iseloomustatud tavalise hüperboolse Michelis-Menteni 
reaktsioonikiiruse võrrandiga (KPEP = 0.11 mM). Samas lülitas cAMP-sõltuva 
proteiinkinaasi poolt katalüüsitud valgu fosforüülimine sisse L-PK kooperatiiv-
suse PEP suhtes ning ka selle ensüümi aktiivsuse allosteerilise regulatsiooni. Nii 
iseloomustas stöhhiomeetriliselt fosforüleeritud ensüümi, kus ühe valgu tetra-
meerse molekuli kohta esines neli fosfaatrühma, KPEP väärtus 2.2 mM ja Hilli 
koefitsient n = 2.5. Samuti ilmnes, et kooperatiivsed omadused lülitusid sisse 
tetrameerse valgu esimese subühiku fosforüleerimisel, kusjuures edasine 
fosfaatrühmade lisamine ainult moduleeris seda efekti. Samuti leiti, et mitte-
fosforüülitud L-PK aktiivsust ei mõjutanud ka allosteeriline aktivaator FBP. 
Kuna fosforüleeritud L-PK aktiivsus suureneb oluliselt allosteerilise aktivaatori 
FBP juuresolekul, siis järeldati, et fosforüleerimine toimib ka selle ensüümi 
allosteerilise regulatsiooni molekulaarse lülitina. 
Regulatoorne fosforüülimine toimub seriini nr 12 juures, mis asub N-termi-
naalses valgujärjestuses MEGPAGYLRR10AS12VAQLTQEL20GTAFF. Selle 
valgujärjestuse rolli selgitamiseks uuriti fosforüülitava seriini ümbruses asuvate 
aminohapete punktmutatsioonide mõju valgu katalüütilistele omadustele. 
Muutused olid positsioonides 9, 10 ja 13 ning asenduseks kasutati amino-
happeid A, L, Q ja E, mis võimaldas muuta selle domeeni summaarset laengut 
ja uurida, kas ioonsete rühmade ümberjaotumine ja uute ioonsete rühmade 
sisseviimine võib imiteerida seriini jäägi fosforüülimise efekti. Ilmnes, et 
mõned asendused mõjutasid valgu aktiivsust, vähendades selle afiinsust PEP 
suhtes ning sellega imiteerisid fosforüülimist. Saadud tulemus on kooskülas 
A. Fentoni ja kaastöötajate poolt pakutud oletusega (Fenton & Tang, 2009; 
Holyoak et al., 2013), et N-domeen võib seostuda valgumolekuli mingis muus 
piirkonnas ja selliselt mõjutada substraadi sidumist. Selle sisemolekulaarse 
kompleksi lõhub aga domeeni fosforüülimine. Samas aga ilmnes tõsiasi, et N-
13
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domeeni struktuuri ja kogulaengu muutmine ei indutseeri ensüümi kooperatiiv-
sust PEP suhtes.  
Lähtudes oletusest, et N-domeen võib tänu oma paindlikkusele toimida 
valgumolekuli teiste osadega, teostati arvutil modelleerimise teel võimalike 
sidumiskohtade otsing. Selleks uuriti regulatoorse domeeni fragmendi 
RRASVA ja selle fosforüülitud analoogi RRAS(Pi)VA seostumist L-PK 
alaühikuga. Leiti, et RRASVA seostumine võib toimuda ensüümi aktiivtsentri 
piirkonnas ning see võib tõepoolest olla oluline PEP sidumise seisukohast. 
Samal ajal toimus fosfopeptiidi sidumine subühiku C-domeenil, kus seostub 
allosteeriline ligand FBP. Seega võib sisemolekulaarsete komplekside teke 
tõepoolest nihutada tasakaalu ensüümi aktiivse R-vormi ja vähemaktiivse  
T-vormi vahel. Samas võib kooperatiivsuse sisselülitamine toimuda fosfo-
rüleeritud N-domeeni seostumisel L-PK allosteerilises tsentris.  
Molekulaarne lülitusmehhanism allosteerilise ja mitte-allosteerilise L-PK 
vormide vahel, mis põhineb regulatoorse domeeni fosforüülimisel, võib omada 
olulist tähtsust maksas toimuva glükoosi metabolism mõistmisel.  
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